The FDA has converted its 2024 accelerated approval of tarlatamab-dlle (Imdelltra) for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) with disease progression during or ...
The FDA has granted approval to sevabertinib (Hyrnuo) for the treatment of patients with locally advanced or metastatic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback